Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CEG vs MRNA✓SelectedUSD · MRNACEG vs MRNA performance historyLatest closeAs of-3.51%11/17
Stock and ETF performance explorer

CEG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+564.1%
MRNA return
+9.5%
Excess return
+554.5%
Maximum drawdown
-50.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.5%-3.9%+0.4%-3.3%
7D+0.3%-17.6%+17.8%+1.2%
30D-1.1%-5.1%+4.1%-0.9%
3M-3.3%+220.8%-224.2%-12.8%
6M+0.6%+321.7%-321.1%-12.7%
YTD-23.7%+601.3%-624.9%-38.6%
1Y-20.4%+735.2%-755.6%-37.6%
3Y+124.4%+170.5%-46.1%+95.9%
All+564.1%+9.5%+554.5%+525.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling